NORTH HAVEN, Conn.--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its Surgical Devices business unit has launched the Versaport™ Plus Bladeless Trocar line for the minimally invasive surgical market worldwide.
